Dysregulated T cell activity and function are hallmarks in the pathogenesis of MS (36), and our pQTL associations of CD58 with MS in large EHRs suggest a causal link to MS and potentially a biomarker for disease severity and therapeutic responses. This evidence concerns the gene CD58 and myeloid sarcoma.